$5.87
-0.16[-2.65%]
At close: Apr 24
$5.87
0[0.00%]
After Hours: 4:00PM EDT
AngioDynamics
(NASDAQ:ANGO)AngioDynamics Stock (NASDAQ:ANGO), Analyst Ratings, Price Targets, Predictions
AngioDynamics Inc has a consensus price target of $17, established from looking at the 17 latest analyst ratings. The last 3 analyst ratings were released from Oppenheimer, Raymond James, and HC Wainwright & Co. on April 5, 2024, January 9, 2024, and January 8, 2024. With an average price target of $13.33 between Oppenheimer, Raymond James, and HC Wainwright & Co., there's an implied 127.14% upside for AngioDynamics Inc from these 3 analyst ratings.
Analyst Firms Making Recommendations1
Oppenheimer
Raymond James
HC Wainwright & Co.
Canaccord Genuity
Canaccord Genuity
1calculated from analyst ratings published within the last 3 years
Analyst Ratings for AngioDynamics
date | ticker | Buy Now | Company | Current price | Upside/Downside | Analyst Firm | Analyst & % Accurate | Price Target Change | Rating Change | Previous / Current Rating | Get Alert |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 04/05/2024 | ANGO | Buy Now | AngioDynamics | $5.87 | 104.43% | Oppenheimer | Steven Lichtman | → $12 | Upgrade | Perform → Outperform | Get Alert |
| 01/09/2024 | ANGO | Buy Now | AngioDynamics | $5.87 | 70.36% | Raymond James | Jayson Bedford | $12 → $10 | Maintains | Outperform | Get Alert |
| 01/08/2024 | ANGO | Buy Now | AngioDynamics | $5.87 | 206.64% | HC Wainwright & Co. | Yi Chen | $20 → $18 | Maintains | Buy | Get Alert |
| 10/06/2023 | ANGO | Buy Now | AngioDynamics | $5.87 | 104.43% | Raymond James | Jayson Bedford | $13 → $12 | Maintains | Outperform | Get Alert |
| 10/05/2023 | ANGO | Buy Now | AngioDynamics | $5.87 | 189.61% | Canaccord Genuity | William Plovanic | $20 → $17 | Maintains | Buy | Get Alert |
| 10/05/2023 | ANGO | Buy Now | AngioDynamics | $5.87 | 240.72% | HC Wainwright & Co. | Yi Chen | $19 → $20 | Maintains | Buy | Get Alert |
| 09/25/2023 | ANGO | Buy Now | AngioDynamics | $5.87 | 223.68% | HC Wainwright & Co. | Yi Chen | → $19 | Initiates | → Buy | Get Alert |
| 07/13/2023 | ANGO | Buy Now | AngioDynamics | $5.87 | 240.72% | Canaccord Genuity | William Plovanic | $18 → $20 | Maintains | Buy | Get Alert |
| 04/17/2023 | ANGO | Buy Now | AngioDynamics | $5.87 | 121.47% | Raymond James | Jayson Bedford | $14 → $13 | Downgrade | Strong Buy → Outperform | Get Alert |
| 04/03/2023 | ANGO | Buy Now | AngioDynamics | $5.87 | 138.5% | Raymond James | Jayson Bedford | $22 → $14 | Maintains | Strong Buy | Get Alert |
| 01/06/2023 | ANGO | Buy Now | AngioDynamics | $5.87 | 274.79% | Raymond James | Jayson Bedford | $25 → $22 | Maintains | Strong Buy | Get Alert |
| 10/07/2022 | ANGO | Buy Now | AngioDynamics | $5.87 | 325.89% | Raymond James | Jayson Bedford | $27 → $25 | Maintains | Strong Buy | Get Alert |
| 07/13/2022 | ANGO | Buy Now | AngioDynamics | $5.87 | 359.97% | Raymond James | Jayson Bedford | $32 → $27 | Maintains | Strong Buy | Get Alert |
| 10/15/2021 | ANGO | Buy Now | AngioDynamics | $5.87 | 530.32% | Canaccord Genuity | William Plovanic | — | Upgrade | Hold → Buy | Get Alert |
| 08/20/2021 | ANGO | Buy Now | AngioDynamics | $5.87 | — | Oppenheimer | Steven Lichtman | — | Initiates | → Perform | Get Alert |
| 07/14/2021 | ANGO | Buy Now | AngioDynamics | $5.87 | 377% | Canaccord Genuity | — | — | Maintains | Hold | Get Alert |
| 07/09/2021 | ANGO | Buy Now | AngioDynamics | $5.87 | 445.14% | Raymond James | Jayson Bedford | — | Maintains | Strong Buy | Get Alert |
FAQ
What is the target price for AngioDynamics (ANGO)?
The latest price target for AngioDynamics (NASDAQ: ANGO) was reported by Oppenheimer on April 5, 2024. The analyst firm set a price target for $12.00 expecting ANGO to rise to within 12 months (a possible 104.43% upside). 8 analyst firms have reported ratings in the last year.
What is the most recent analyst rating for AngioDynamics (ANGO)?
The latest analyst rating for AngioDynamics (NASDAQ: ANGO) was provided by Oppenheimer, and AngioDynamics upgraded their outperform rating.
When was the last upgrade for AngioDynamics (ANGO)?
The last upgrade for AngioDynamics Inc happened on April 5, 2024 when Oppenheimer raised their price target to $12. Oppenheimer previously had a perform for AngioDynamics Inc.
When was the last downgrade for AngioDynamics (ANGO)?
The last downgrade for AngioDynamics Inc happened on April 17, 2023 when Raymond James changed their price target from $14 to $13 for AngioDynamics Inc.
When is the next analyst rating going to be posted or updated for AngioDynamics (ANGO)?
Analysts arrive at stock ratings after doing extensive research, which includes going through public financial statements, talking to executives and customers of AngioDynamics, and listening in to earnings conference calls. Most analysts do this every three months, so you should get 4 ratings per company per firm each year. The last rating for AngioDynamics was filed on April 5, 2024 so you should expect the next rating to be made available sometime around April 5, 2025.
Is the Analyst Rating AngioDynamics (ANGO) correct?
While ratings are subjective and will change, the latest AngioDynamics (ANGO) rating was a upgraded with a price target of $0.00 to $12.00. The current price AngioDynamics (ANGO) is trading at is $5.87, which is within the analyst’s predicted range.
Browse analyst ratings and price targets on all stocks.